Bio-Techne TECH Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's total liabilities & equity?
- Bio-Techne (TECH) reported total liabilities & equity of $2.55B in Q1 2026.
- How has Bio-Techne's total liabilities & equity changed year-over-year?
- Bio-Techne's total liabilities & equity decreased by 3.5% year-over-year, from $2.64B to $2.55B.
- What is the long-term trend for Bio-Techne's total liabilities & equity?
- Over 4 years (2021 to 2025), Bio-Techne's total liabilities & equity has grown at a 3.1% compound annual growth rate (CAGR), from $2.26B to $2.56B.
- What does total liabilities & equity mean?
- The total value of all liabilities and equity, representing the company's total financing.
- How do you interpret total liabilities & equity?
- Growth in this metric generally tracks the overall growth of the company's asset base and operational scale.
- How does total liabilities & equity compare across companies?
- Used as a baseline for comparing the size and scale of companies within the same industry.